Zeiss Convivo on display, page-5

If the biggest European medical company with a market capitalisation of 6.51B Euros and a continued rising Sp with as per today at 74.70 Euros has ZEISS’s (Optiscan’s) ConVivo as one of only two product in its monthly newsletter as highlights for its EANS in Brüssel mentioned, actually tells how confident they are having a product ready for sale the world’s medical community must be interested in! There shouldn’t be any doubt about approval and coming sales success on the world market anymore! The frustration about OIL’s current idiotic SP remains, but only 5 days to go which should fix this quick smart!